Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.
Document Type
Journal Article
Publication Date
3-1-2021
Journal
The British Journal of Ophthalmology
Volume
105
Issue
3
Inclusive Pages
414-419
DOI
10.1136/bjophthalmol-2020-315984
APA Citation
Mansour, S. E., Kiernan, D., Roth, D., Eichenbaum, D., Holekamp, N., Kaba, S., & Werts, E. (2021). Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.. The British Journal of Ophthalmology, 105 (3). http://dx.doi.org/10.1136/bjophthalmol-2020-315984
Peer Reviewed
1
Comments
Epub 2020 May 27